Author Archive for Insider Scoop

Earnings Scheduled For July 6, 2015

Courtesy of Benzinga.

Earnings Scheduled For July 6, 2015

Related SHLM
7 Stocks You Should Be Watching Today
Must Watch Stocks for Today
Notable earnings after Monday's close (Seeking Alpha)

Related OPTT
Ocean Power Technologies' PB40 PowerBuoy Receives Final Permit Approvals for Deployment
Earnings Scheduled For March 11, 2015

A Schulman Inc (NASDAQ: SHLM) is expected to post its Q3 earnings at $0.77 per share on revenue of $608.97 million.

Ocean Power Technologies Inc (NASDAQ: OPTT) is estimated to post a Q4 loss at $0.21 per share on revenue of $360.00 thousand.

Posted-In: Earnings scheduleEarnings News Pre-Market Outlook Markets





Benzinga's Top Downgrades

Courtesy of Benzinga.

Benzinga's Top Downgrades

Related RPTP
Oppenheimer Downgrades Raptor Pharmaceutical To Underperform
Oppenheimer Warns Raptor Pharma Could Fall By ~50%, Suggests 'Sell While You Can'

Related CNC
Barclays Downgrades Centene To Equal-weight
Mid-Afternoon Market Update: International Speedway Slips On Weak Results; Applied Genetic Technologies Shares Spike Higher
Health Net (HNT) to Be Acquired by Centene for $6.8 Billion – Analyst Blog (Zacks)

Analysts at Oppenheimer downgraded Raptor Pharmaceutical Corp. (NASDAQ: RPTP) from Perform to Underperform. Raptor Pharmaceutical’s shares closed at $15.79 on Thursday.

Analysts at Barclays downgraded Centene Corp (NYSE: CNC) from Overweight to Equal-weight. The price target for Centene has been lowered from $88.00 to $81.00. Centene shares closed at $74.45 on Thursday.

Analysts at UBS downgraded Celanese Corporation (NYSE: CE) from Buy to Neutral. The price target for Celanese has been raised from $69.00 to $74.00. Celanese shares closed at $73.72 on Thursday.

Analysts at Morgan Stanley downgraded Intuitive Surgical, Inc. (NASDAQ: ISRG) from Equal-weight to Underweight. Intuitive Surgical shares closed at $486.29 on Thursday.

Citigroup downgraded BT Group plc (ADR) (NYSE: BT) from Buy to Neutral. BT Group’s shares closed at $71.16 on Thursday.

FBR Capital downgraded VMware, Inc. (NYSE: VMW) from Outperform to Market Perform. VMware shares closed at $85.17 on Thursday.

Guggenheim Securities downgraded Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR) from Neutral to Sell. Aegerion Pharmaceuticals’ shares closed at $18.59 on Thursday.

KeyBanc downgraded CIRCOR International, Inc. (NYSE: CIR) from Overweight to Sector Weight. CIRCOR International’s shares closed at $52.87 on Thursday.

BB&T Capital downgraded HORSEHEAD HOLDING CORP. (NASDAQ: ZINC) from Buy to Hold. Horsehead Holding’s shares closed at $11.45 on Thursday.

Stephens & Co. downgraded ACI Worldwide Inc (NASDAQ: ACIW) from Overweight to Equal-weight. The price target for ACI Worldwide is set to $26. ACI Worldwide shares closed at $24.33 on Thursday.

Latest Ratings for RPTP

Date Firm Action From To
Jul 2015 Oppenheimer Downgrades Perform Underperform
Jun 2015 Citigroup Initiates Coverage on Buy
Apr 2015 Janney Capital Initiates Coverage on Buy

View More Analyst Ratings for RPTP
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings





FBR Downgrades Aetna: Humana Is 'Nice,' But Results Are Inconsistent

Courtesy of Benzinga.

Related AET
Aetna-Humana Deal Are 'Right Partners,' Companies Say
Benzinga's Top #PreMarket Losers
Premarket Gainers / Losers (Seeking Alpha)

Related HUM
Aetna-Humana Deal Are 'Right Partners,' Companies Say
Benzinga's Top #PreMarket Losers
Today's Market: Another Merger Monday As Greece Weighs On Stocks (Seeking Alpha)

In a report published Monday, FBR Capital Markets analyst Steven Halper downgraded the rating on Aetna Inc (NYSE: AET) from Outperform to Market Perform, while raising the price target from $120 to $130, after the company announced plans to acquire Humana Inc (NYSE: HUM) (rated Market Perform).

Aetna intend to acquire Humana for $230. “Given its large presence in Medicare Advantage, Humana is a nice asset, but results have been inconsistent. With an acquisition price of $230 per HUM share, a reasonable level of synergies, and a 54/46 cash/stock split, we estimate nominal EPS accretion,” analyst Steven Halper mentioned.

Aetna’s management expects the acquisition to be neutral in 2016 and result in mid-single-digit percentage accretion in 2017.

Post acquisition, the company’s revenue mix is expected to skew more in favor of government sources. The revenue from government sources is expected to increase from 40 percent at present to 65 percent after the integration.

“Given the change in mix, integration risk, and limited upside to our revised price target, we are lowering our rating on AET shares to Market Perform from Outperform,” Halper added.

In the report FBR Capital Markets noted, “Aetna/HUM will have to increase pricing in 2017 and/or change its network approach in order to improve the profitability of its MA and exchange-based plans.”

“Given its investment in its Accountable Care Solution products, we believe the company is likely to be a net market share gainer over the longer term,” the report added.

Latest Ratings for AET

Date Firm Action From To
Jul 2015 FBR Capital Downgrades Outperform Market Perform
Jun 2015 Leerink Swann Maintains Outperform
Jun 2015 RBC Capital Initiates Coverage on Sector Perform

View More Analyst Ratings for AET
View the Latest Analyst Ratings

Posted-In: FBR Capital MarketsAnalyst Color Downgrades Price Target Analyst Ratings





Barclays Upgrades Tripadvisor To Equal-weight

Courtesy of Benzinga.

Related TRIP
Barclays Upgrades Tripadvisor, Says Marriott Partnership Is 'First Of Many'
Exclusive: Airline ETF Manager Weighs In On Industry In Light Of DOJ Investigation

Analysts at Barclays upgraded Tripadvisor Inc (NASDAQ: TRIP) from Underweight to Equal-weight.

The price target for Tripadvisor has been raised from $68.00 to $84.00.

Tripadvisor shares have dropped 19.12 percent over the past 52 weeks, while the S&P 500 index has surged 5.01 percent in the same period.

Tripadvisor shares fell 0.03 percent to close at $86.87 on Thursday.

Latest Ratings for TRIP

Date Firm Action From To
Jul 2015 Barclays Upgrades Underweight Equal-weight
Jun 2015 Barclays Initiates Coverage on Underweight
May 2015 Guggenheim Securities Initiates Coverage on Buy

View More Analyst Ratings for TRIP
View the Latest Analyst Ratings

Posted-In: BarclaysUpgrades Analyst Ratings





Benzinga's Top #PreMarket Losers

Courtesy of Benzinga.

Related ALLT
Benzinga's Top Downgrades
Barclays Downgrades Allot Communications To Underweight

Related CLNE
5 Small-Cap Utilities Stocks With The Highest EPS Growth Forecast For Next 5 Years
Monday Morning Market Movers: Lumber Liquidators Off +24%

Allot Communications Ltd (NASDAQ: ALLT) shares declined 11.06 percent to $6.30 in pre-market trading. Allot Communications issued a weak Q2 and FY revenue guidance.

Energy XXI Ltd (NASDAQ: EXXI) shares dropped 8.23 percent to $2.12 in pre-market after falling 7.23 percent on Thursday.

Aetna Inc (NYSE: AET) shares tumbled 5.74 percent to $118.30 in pre-market trading after the company announced its plans to acquire Humana Inc (NYSE: HUM) in a cash-and-stock deal valued at $35 billion.

Clean Energy Fuels Corp (NASDAQ: CLNE) shares fell 5.03 percent to $5.10 in pre-market trading after dropping 0.56 percent on Thursday.

JD.Com Inc(ADR) (NASDAQ: JD) fell 3.41 percent to $32.00 in pre-market trading after declining 0.36 percent on Thursday.

Posted-In: PreMarket LosersNews Movers & Shakers Pre-Market Outlook Markets





CRT Capital Upgrades United Continental To Buy, Sees Merger Integration In 'Seventh Inning'

Courtesy of Benzinga.

Related UAL
Benzinga's Top Upgrades
CRT Capital Upgrades United Continental To Buy
How Delta Air Lines Sticks Out From The Airline Industry (Seeking Alpha)

In a report published Monday, CRT Capital analyst Michael Derchin upgraded the rating on United Continental Holdings Inc (NYSE: UAL) from Fair Value to Buy, with a price target of $70.

United Continental is focusing on improving its margins, generating more cash flows and enhancing its core earnings.

“With merger integration in the seventh inning, and putting out integration “fires” mostly a thing of the past, UAL is now fully focused on margin improvement, free cash flow generation, core earnings improvement, and capacity and financial discipline, in our view,” analyst Michael Derchin wrote.

The company now needs to complete the negotiation of joint collective bargaining agreements with its flight attendants and technicians. United Continental is also yet to develop a new maintenance planning system.

In the report CRT Capital noted that the company was proactively working on controlling its costs and enhancing revenues to improve profitability.

“A recent example of UAL’s proactive focus on cost control and revenue enhancement programs to improve profitability in the seasonally weak first and fourth quarters is the announced suspension of transcontinental service at New York’s JFK Airport, a long-term loss operation, and redeployment of assets to its highly profitable, core Newark hub,” the report added.

Near-term catalysts for the company include “accelerated buy backs in the recent sharp sell-off, re-authorization of the new $1 billion share buy-back program and improving unite revenue outlook for third and fourth quarters,” Derchin stated.

Latest Ratings for UAL

Date Firm Action From To
Jul 2015 Sterne Agee CRT Upgrades Fairly Valued Buy
Jun 2015 Morgan Stanley Initiates Coverage on Overweight
Jun 2015 Barclays Maintains Overweight

View More Analyst Ratings for UAL
View the Latest Analyst Ratings

Posted-In: CRT CapitalAnalyst Color Upgrades Analyst Ratings





FBR Upgrades Ares Commercial's 'Show Me Story'

Courtesy of Benzinga.

FBR Upgrades Ares Commercial's 'Show Me Story'

Related ACRE
Right Time to Build Positions in REIT Stocks? – Zacks Analyst Interviews
UPDATE: JMP Securities Reiterates On Ares Commercial Real Estate On Near-Term Earnings Drag

In a report issued Monday, FBR & Co. analysts Daniel Altscher and Cole Allen upgraded their rating on shares of Ares Commercial Real Estate Corp (NYSE: ACRE) from Market Perform to Outperform, while raising their price target from $12.50 to $13.00 after meeting with the company’s management.

Prior to the recently held investor meetings with management, the firm believed the small-cap company had much “to prove in terms of fundamental performance” before it could become positive on the stock. While the current situation may not be perfect, the analysts consider enough progress has been made, especially in ACRE Capital, to warrant their Outperform rating.

Related Link: Investing In NYC Real Estate Via CityFunders Crowdfunding Platform

According to the research note, the specialists at FBR are “aware of some of the pushback around the stock (e.g., ~$340 million market cap, smaller-than-peer balance sheet, little access to equity capital, negative sentiment remnants from nearly two years ago that just cannot be washed away, etc.),” but still believe investors with a focus on small-caps “owe it to themselves to look at this value stock trading at ~80 percent of book value that is in an active transformation.”

Why Turning Around ACRE Capital Matters?

Since its acquisition was announced in May 2013, the unit has not contributed to earnings and has delivered inconsistent performance. However, this trend seems to have reverted in the past couple of quarters and should continue in the right track, the experts think. Additionally, the unit could represent a sellable asset, at the very least.

Related Link: Realquidity Wants To Be The NASDAQ Of Real Estate

Other Factors

A few other key elements supporting FBR’s upgrade include “favorable asset sensitivity to higher short-term interest rates, a floor under the stock with a buyback authorization now put in place and inexpensive valuation on a book value per share basis.”

Shares of Ares are up about 1.4 percent on Monday trading.

Image Credit: Public Domain

Latest Ratings for ACRE

Date Firm Action From To
Jul 2015 FBR Capital Upgrades Market Perform Outperform
Mar 2015 JMP Securities Maintains Market Outperform
Mar 2015 Keefe Bruyette & Woods Maintains Market Perform

View More Analyst Ratings for ACRE
View the Latest Analyst Ratings

Posted-In: Analyst Color Long Ideas Upgrades Price Target Analyst Ratings Movers Trading Ideas Real Estate





New Wall Street Coverage: GoPro, Kraft Heinz And More

Courtesy of Benzinga.

Related
Benzinga's Top Initiations
Jefferies Initiates Axovant Sciences At Buy
According to analyst, Axovant's RVT-101 could be a blockbuster or maybe not (Seeking Alpha)

Related
Stifel Starts Biotie At Buy, Says Lead Product Can 'Meaningfully Improve' Parkinson's Patients
Benzinga's Top Initiations

A few stocks saw coverage initiation on Monday. Here's a recap in case you missed it.

Axovant Sciences Ltd (NYSE: AXON)

  • RBC Capital – Initiated with Outperform rating; $40 price target.
  • Jefferies Group – Buy rating; $31 price target.
  • Evercore Partners – Buy rating; $29 price target.

Biotie Therapies (NASDAQ: BITI)

  • Stifel Nicolaus – Initiated with Buy rating; $30 price target.
  • RBC Capital – Outperform rating; $35 price target.
  • JMP Securities – Outperform rating; $32 price target.

GoPro Inc (NASDAQ: GPRO)

  • Goldman Sachs – Initiated with Neutral rating; $60 price target.

Kraft Heinz Co (NASDAQ: KHC)

  • Credit Suisse – Initiated with Outperform rating; $85 price target.

Latest Ratings for AXON

Date Firm Action From To
Jul 2015 Jefferies Initiates Coverage on Buy
Jul 2015 RBC Capital Initiates Coverage on Outperform
Jul 2015 Evercore Partners Initiates Coverage on Buy

View More Analyst Ratings for AXON
View the Latest Analyst Ratings

Posted-In: Price Target Initiation Analyst Ratings





How The Street Is Reacting To The Aetna-Humana Deal

Courtesy of Benzinga.

How The Street Is Reacting To The Aetna-Humana Deal
Related AET
Aetna CEO Sees Divestitures As 'Very Manageable' In Humana Merger
Mid-Day Market Update: Weight Watchers Surges On Takeover Rumors; Horsehead Holding Shares Drop
Walgreens To Report Q3 Amid Industry Consolidation (Investor’s Business Daily)
Related HUM
Aetna CEO Sees Divestitures As 'Very Manageable' In Humana Merger
Mid-Day Market Update: Weight Watchers Surges On Takeover Rumors; Horsehead Holding Shares Drop
Walgreens To Report Q3 Amid Industry Consolidation (Investor’s Business Daily)

Aetna Inc (NYSE: AET) reached a deal early Friday morning to buy out rival health insurer Humana Inc (NYSE: HUM) for a combination of cash and stock. The $37 billion agreement valued Humana at $230 per share, 23 percent higher than its closing price on Thursday.

Analysts on the Street have mixed thoughts about the acquisition.

Joseph France, Cantor Fitzgerald

France saw the deal as favorable from the perspectives of both parties. He noted that Humana was bought out at a “substantial premium.” On the other hand, he thought the transaction was “potentially transformative” for Aetna.

France reiterated his Buy rating on Humana, giving the company a $230 price target.

Related Link: Aetna–Humana Deal Are “Right Partners,” Companies Say

Christine Arnold, Cowen

According to Arnold, the purchase price extended by Aetna was “steep.”

She also raised concerns that the deal would probably be “heavily scrutinized by state regulators. She mentioned combined market share in Florida, Georgia, Illinois and Kansas as the “biggest hurdles.”

Nevertheless, she gave Aetna an Outperform rating and a price target of $145.

Steven Halper, FBR

Halper said that Aetna would now have to increase 2017 pricing and/or change its networking strategy in order to increase the profitability of its Medicare Advantage and exchange-based plans.

He believes, however, that integration of Humana into Aetna operations will prove a “difficult task.”

Halper cut his Aetna price target…
continue reading





Russian Inflation Expected To Continue To Fall

Courtesy of Benzinga.

Russian Inflation Expected To Continue To Fall

Related RSX
Russia's Gazprom Reportedly Shuts Off Gas Delivery To Ukraine
ETF Investors Aren't Afraid Of Greek Default
Snake Oil Stats (Seeking Alpha)

In a report published Friday, Barclays analyst Daniel Hewitt explained that the inflation in Russia has continued to decline. The PMI for June for Central Europe rose to an average of 55, while that for Russia rose to below 50.

“With inflation dropping rapidly, we expect it to decline to 15.4 percent year on year from a high of 16.9 percent in March. This will mean that Q2 inflation has been a little over 1 percent, implying an annualized rate of just 4 percent, in line with the CBR medium-term target,” Hewitt stated.

The analyst expects the rate of inflation to increase marginally, driven by planned adjustments in the July utility prices, along with RUB depreciation that has been ongoing since mid-May. ‘Nevertheless, we think the high interest rates and low liquidity growth that has brought inflation under control will persist,” Hewitt added.

In addition, there is downward pressure on prices due to the low growth rate. The analyst expects Russia’s Q2 current account data to decline to nearly $11 billion, driven by seasonal factors.

Posted-In: Barclays Daniel HewittAnalyst Color Analyst Ratings Best of Benzinga





 
 
 

Zero Hedge

The Biggest Winner From The Greek Tragedy

Courtesy of ZeroHedge. View original post here.

Submitted by Tyler Durden.

Long after Greece has left the Eurozone and Germany is using the Deutsche Mark as its currency, the people of the two nations, antagonized to a level unseen since World War II, will be accusing each other of benefiting more from the brief but tumultuous period of the common currency.

In reality, nobody had put a gun to Greece's head and told it to lever up, enriching local oligarchs and corrupt politicians, taking advantage of credit that was artificially cheap only due to the common currency and an implicit monetary, if not fiscal, union.

Germany, whose exports account for nearly 50% of GDP, on the other hand experienced an unprecedented exporting golden age, made possible only due to an artificial currency...



more from Tyler

Market News

News You Can Use From Phil's Stock World

 

Financial Markets and Economy

The amount of money Americans say they spend in a day has gone basically nowhere in the last two years (Business Insider)

Gallup just released the results of a poll asking Americans how much money they spent in a day on discretionary items, excluding major home purchases and regular bills. Respondents are asked how much they spent "yesterday," or the day before they were contacted by the pollster.

Chinese Stocks Open Down Ha...



more from Paul

Chart School

RTT browsing latest..

Courtesy of Read the Ticker.

Please review a collection of WWW browsing results.Date Found: Friday, 05 June 2015, 03:53:56 PM

Click for popup. Clear your browser cache if image is not showing. Comment: FAIR QUESTION: is the Fed simply rising rates just so it badly crashes the economy and has the cover to launch QE4, the same way Russian sanctions crippled Germany's economy and led to the ECB's very first episode of bond monetization?

Date Found: Friday, 05 June 2015, 08:54:03 PM

Click for popup. Clear your browser cache if image is not showing. Comment: Zerohedge : This is the simplest way to describe Keynesianism: A slow steady rise up, with quick steps down towards where you came from.

Date Found: Saturday, 06 June 2015, 02:12:32 AM...

more from Chart School

Sabrient

Sector Detector: Bulls prepare for a new buying opportunity, courtesy of Greece

Reminder: Sabrient is available to chat with Members, comments are found below each post.

Courtesy of Sabrient Systems and Gradient Analytics

Of course, all eyes have been on Greece in an ongoing saga that, although critical to the Greeks, is mostly just an annoying distraction for global investors -- partly because it has been going on for so many years, with the proverbial can of inevitability continually being kicked down the road, and partly because there can be no winners in this intractable situation. Predictably, the electorate chose to follow the advice of the communists that they elected and reject the rigid bailout offer, calling the bluff of the IMF, ECB, and Eurozone and betting they will do whatever it takes to avoid losing one of its members. These are uncharted waters, and with the resultant s...



more from Sabrient

Phil's Favorites

There is Only One Way Out For Greece

Courtesy of Martin Armstrong via ArmstrongEconomics

Brussels has been dead wrong. The stupid idea that the euro will bring stability and peace, as it was sold from the outset, has migrated to European domination as if this were “Game of Thrones.” Those in power have misread history, almost at every possible level. The assumption that the D-marks’ strength was a good thing that would transfer to the euro has failed because they failed to comprehend the backdrop to the D-mark.

Germany moved opposite of the USA toward extreme austerity and conservative economics because of its experience with hyperinflation. The USA moved toward stimulation because of the austerity policies that created the Great Depression, which led to a sh...



more from Ilene

Kimble Charting Solutions

Leading indicator breakdowns, more important than Greece?

Courtesy of Chris Kimble.

Has Greece been a good economic indicator over the past few years? Most would say NOT!

Could Crude & Copper be sending a more important global message than what happens in Greece?

A year ago a long-term pennant pattern in play with Crude Oil. Once it started heading south a year ago, it fell hard. Crude Oil’s rally took it 23% retracement level and its 200MA line of late at (1) below. See what is happening now!

CLICK ON CHART ENLARGE

Crude is breaking below this multi-week pennant pattern after failing to climb above Fibonacci resistance and its 200ma...



more from Kimble C.S.

OpTrader

Swing trading portfolio - week of July 6th, 2015

Reminder: OpTrader is available to chat with Members, comments are found below each post.

 

This post is for all our live virtual trade ideas and daily comments. Please click on "comments" below to follow our live discussion. All of our current  trades are listed in the spreadsheet below, with entry price (1/2 in and All in), and exit prices (1/3 out, 2/3 out, and All out).

We also indicate our stop, which is most of the time the "5 day moving average". All trades, unless indicated, are front-month ATM options. 

Please feel free to participate in the discussion and ask any questions you might have about this virtual portfolio, by clicking on the "comments" link right below.

To learn more about the swing trading virtual portfolio (strategy, performance, FAQ, etc.), please click here ...



more from OpTrader

Digital Currencies

Bitcoin Surges After Initial Forecasts Show "No" Vote Ahead

Courtesy of ZeroHedge. View original post here.

Submitted by Tyler Durden.

If the early bitcoin markets are an indication of what will happen once New Zealand opens for illiquid FX trade, it will be a risk off kinda day.

And that doesn't even take into account the pandemonium that will be unleashed in China in a few hours after the PBOC just went all-in to halt the crashing stock market. What if it fails to get a green close before tomorrow's US open?

Source: ...



more from Bitcoin

All About Trends

Mid-Day Update

Reminder: David is available to chat with Members, comments are found below each post.

Click here for the full report.




To learn more, sign up for David's free newsletter and receive the free report from All About Trends - "How To Outperform 90% Of Wall Street With Just $500 A Week." Tell David PSW sent you. - Ilene...

more from David

Pharmboy

Baxter's Spinoff

Reminder: Pharmboy and Ilene are available to chat with Members, comments are found below each post.

Baxter Int. (BAX) is splitting off its BioSciences division into a new company called Baxalta. Shares of Baxalta will be given as a tax-free dividend, in the ratio of one to one, to BAX holders on record on June 17, 2015. That means, if you want to receive the Baxalta dividend, you need to buy the stock this week (on or before June 12).

The Baxalta Spinoff

By Ilene with Trevor of Lowenthal Capital Partners and Paul Price

In its recent filing with the SEC, Baxter provides:

“This information statement is being ...



more from Pharmboy

Mapping The Market

An update on oil proxies

Courtesy of Jean-Luc Saillard

Back in December, I wrote a post on my blog where I compared the performances of various ETFs related to the oil industry. I was looking for the best possible proxy to match the moves of oil prices if you didn't want to play with futures. At the time, I concluded that for medium term trades, USO and the leveraged ETFs UCO and SCO were the most promising. Longer term, broader ETFs like OIH and XLE might make better investment if oil prices do recover to more profitable prices since ETF linked to futures like USO, UCO and SCO do suffer from decay. It also seemed that DIG and DUG could be promising if OIH could recover as it should with the price of oil, but that they don't make a good proxy for the price of oil itself. 

Since...



more from M.T.M.

Promotions

Watch the Phil Davis Special on Money Talk on BNN TV!

Kim Parlee interviews Phil on Money Talk. Be sure to watch the replays if you missed the show live on Wednesday night (it was recorded on Monday). As usual, Phil provides an excellent program packed with macro analysis, important lessons and trading ideas. ~ Ilene

 

The replay is now available on BNN's website. For the three part series, click on the links below. 

Part 1 is here (discussing the macro outlook for the markets) Part 2 is here. (discussing our main trading strategies) Part 3 is here. (reviewing our pick of th...

more from Promotions

Help One Of Our Own PSW Members

"Hello PSW Members –

This is a non-trading topic, but I wanted to post it during trading hours so as many eyes can see it as possible.  Feel free to contact me directly at jennifersurovy@yahoo.com with any questions.

Last fall there was some discussion on the PSW board regarding setting up a YouCaring donation page for a PSW member, Shadowfax. Since then, we have been looking into ways to help get him additional medical services and to pay down his medical debts.  After following those leads, we are ready to move ahead with the YouCaring site. (Link is posted below.)  Any help you can give will be greatly appreciated; not only to help aid in his medical bill debt, but to also show what a great community this group is.

http://www.youcaring.com/medical-fundraiser/help-get-shadowfax-out-from-the-darkness-of-medical-bills-/126743

Thank you for you time!




FeedTheBull - Top Stock market and Finance Sites



About Phil:

Philip R. Davis is a founder Phil's Stock World, a stock and options trading site that teaches the art of options trading to newcomers and devises advanced strategies for expert traders...

Learn more About Phil >>


As Seen On:




About Ilene:

Ilene is editor and affiliate program coordinator for PSW. She manages the site market shadows, archives, more. Contact Ilene to learn about our affiliate and content sharing programs.

Market Shadows >>